CD209 and COVID-19: Although there is an established link between severe COVID‐19 and endothelial damage through binding to ACE2, the virus can utilise alternative entry receptors through interactions with the spike protein, like CD209L (also known as L‐SIGN) and its homologous protein CD209 (also known as DC‐SIGN), that are highly expressed in virally targeted tissues.30, 31, 32, 33, 34, 35, 36, 37, 38